Stay updated on Tislelizumab & Sitravatinib in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Tislelizumab & Sitravatinib in NSCLC Clinical Trial page.

Latest updates to the Tislelizumab & Sitravatinib in NSCLC Clinical Trial page
- Check6 days agoChange DetectedA new revision entry (v3.7.0) has been added to the study record history, and the older revision (v3.6.6) has been removed from the list, updating the version history shown on the page.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe record history now includes a new revision entry: Revision: v3.6.6, replacing the previous Revision: v3.6.5.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page history shows a new site revision (v3.6.5) replacing v3.6.4, indicating a deployment update rather than changes to study data.SummaryDifference0.1%

- Check62 days agoChange DetectedThe history page shows the revision tag updated from v3.6.3 to v3.6.4, indicating a software update to the page's interface. The change does not modify study data, outcomes, or other substantive content.SummaryDifference0.1%

- Check84 days agoChange DetectedAdded a new revision tag 'Revision: v3.6.3' to the study record history. The previous revision tag 'Revision: v3.6.2' is removed from the current history view.SummaryDifference0.1%

- Check91 days agoChange DetectedThe history now includes a new page revision labeled v3.6.2, replacing the previous v3.6.0 entry.SummaryDifference0.1%

Stay in the know with updates to Tislelizumab & Sitravatinib in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tislelizumab & Sitravatinib in NSCLC Clinical Trial page.